Cold, the article that I was working on actually went into more detail about the unique niche that Cryoport has carved out for themselves in the market, and why it is NOT just another logistics company like the ones mentioned. It was geared toward an audience that is unfamiliar with the company, and it included why the regenerative therapy logistics solutions need to integrate the patient scheduling, the chain of identity, chain of custody, complete data monitoring across all portals, etc. etc., and it also included the partnerships with Fed Ex, UPS, and DHL (who account for 85% of the global airfreight business) and noted that they ALL have chosen to license Cryoport’s solutions rather than develop their own. The point of my post was to show that Cryoport is actually in a very strong competitive position, but I was lazy and simply used cut and paste on some relevant portions of the article. It was difficult to do this while also trying not to post info that is already well known to this board and I readily admit that the post was abbreviated and some of the competitive strengths of Cryyoport were not included, so it “only scratched the surface.”
News 
Market Data 
Discover 
